Concepedia

Publication | Open Access

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

257

Citations

18

References

2021

Year

Abstract

This tubeless automated insulin delivery system was safe and allowed participants to significantly improve HbA<sub>1c</sub> levels and time in target glucose range with a very low occurrence of hypoglycemia.

References

YearCitations

Page 1